What does taking part in these studies involve?
Step 1: Do you qualify for one of these studies?
The screening information below is the first step in determining if
you are qualified for these studies. Carefully review "Who may
participate in these studies." If you meet the criteria and you are
interested, you can indicate your interest by proceeding to Step 2.
Who may participate in these studies?
ESPECIALLY NEEDED
Individuals with active AD or who have outgrown AD and also have a
history of widespread herpes virus skin infection (also called eczema herpeticum), molluscum contagiosum (pearly wart-like skin lesions), or eczema vaccinatum (adverse reaction to smallpox vaccination).
Even though we are enrolling people regardless of race and
ethnicity, we have a special need to enroll African Americans in these
studies because African Americans may be at a greater risk. This risk
may be related to a different genetic background.It involves entry into the ADVN Registry study. In this study, we
will collect your health information and a small amount of blood. In
addition, we will ask you to agree to be contacted in the future to see
if you are interested in taking part in other ADVN studies.If you agree to take part in other ADVN studies, a skin biopsy may be needed.
- Males and females of any race who have active AD
- Males and females of any race who have outgrown AD (even if it has been inactive for many years)
- 1 to 80 years of age
- No other serious illness
- Those under age 18 must have a parent or legal guardian provide informed consent on their behalf
- Even though we are enrolling people regardless of race and
ethnicity, we have a special need to enroll African Americans in these
studies because they may be at greater risk. This risk may be related
to a different genetic background.
Step 2: How to indicate interest in these studies
Participating in these studies is your choice. If you are interested
in participating in these studies, please call the Center nearest you
or our toll free number 1-888-413-5852.
Participating Centers
National Jewish Health, Denver, CO
Phone: 303-398-1067, e-mail TaylorP@njhealth.org
Oregon Health & Science University, Portland, OR
503-228-7350, e-mail keenem@ohsu.edu
University of California at San Diego, San Diego, CA
858-657-8390, e-mail derm@ucsd.edu
Children’s Hospital Boston, Boston, MA
617-355-6127, e-mail advnstudy@childrens.harvard.edu
Johns Hopkins Hospital, Pediatric Immunology, Baltimore, MD
410-614-5467, e-mail krimell1@jhmi.edu
University of Rochester, Rochester, New York
585-275-0374, e-mail ADVN@urmc.rochester.edu
What will you receive for your participation?
- Study related medical evaluation, including physical exam
- Education and information about atopic dermatitis
- Financial compensation for qualified participants
This project has been funded in whole or in part with federal funds
from the National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Department of Health and Human Services,
under contract No. HHSN266200400029C.
